20101206
 Corporate News: CEO's Stress Worried Pfizer --- Board Sought Lieutenant to Share Load, but Kindler Abruptly Decided to Retire   By Lublin, Joann S; Rockoff, Jonathan D, The Wall Street Journal,  Dec 7, 2010  Mr. Kindler had limited experience running a global company the size of Pfizer, and he reacted personally to difficulties like its depressed stock price and pipeline failures, according to people familiar with the situation. Pfizer has been able to "deliver steady, consistent adjusted earnings results, to return cash to shareholders, and to make disciplined investments in medicines that will produce good returns for our shareholders," he told investors and analysts last month in a conference call about third-quarter earnings.   
